Log in
Enquire now
Lycera

Lycera

A company focused on developing immunotherapy treatments for autoimmune disease and cancer

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
AngelList URL
angel.co/lycera
B2X
B2B
B2B
CEO
Paul Sekhri
Paul Sekhri
CIK Number
1,382,268
Company Operating Status
Active
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...n/lycera
Date Incorporated
2006
Founded Date
2006
0
Founder
Gary D. Glick
Gary D. Glick
‌
Anthony Opipari
Full Address
620 W. Germantown Pike Plymouth Meeting, PA 19462
0
1350 Highland Drive Suite A Ann Arbor, MI 48108 United States
0
Industry
Technology
Technology
Biopharma
Biopharma
Autoimmune disease
Autoimmune disease
‌
Pharmaceuticals
Biotechnology
Biotechnology
Biology
Biology
Investors
ARCH Venture Partners
ARCH Venture Partners
Wolverine Venture Fund
Wolverine Venture Fund
0
EDF Ventures
EDF Ventures
Clarus Ventures
Clarus Ventures
InterWest Partners
InterWest Partners
Latest Funding Round Date
June 2015
Latest Funding Type
Series B
Series B
LinkedIn URL
@company/lycera
Location
Ann Arbor, Michigan
Ann Arbor, Michigan
0
Plymouth Meeting, Pennsylvania
Plymouth Meeting, Pennsylvania
0
Number of Employees (Ranges)
10,001+
0
Patents Assigned (Count)
28
Spun Out From
University of Michigan
University of Michigan
Total Funding Amount (USD)
123,817,556
Twitter URL
@lyceracorp
Official Website
lycera.com
Wellfound ID
lycera
Wikidata ID
Q30269117

Find more companies like Lycera

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.